Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus

Human Gene Therapy

Volumn 23, Issue 11, 2012, Pages 1166-1175

  Jiang, Bo ^a   Du, Liang ^a   Flynn, Rowan ^a   Dronadula, Nagadhara ^a   Zhang, Jingwan ^a   Kim, Francis ^a   Dichek, David ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HELPER DEPENDENT ADENOVIRUS VECTOR; MESSENGER RNA; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLONING; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; EXPERIMENTAL RABBIT; GENE OVEREXPRESSION; HYPERLIPIDEMIA; HYPOTHESIS; IN VIVO GENE TRANSFER; INFLAMMATION; LIPID STORAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; ARTERIES; ATHEROSCLEROSIS; CAROTID ARTERIES; CATTLE; CELL ADHESION MOLECULES; CYTOKINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC VECTORS; MALE; NITRIC OXIDE SYNTHASE TYPE III; RABBITS; RNA, MESSENGER; VASODILATION;

ADENOVIRIDAE; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS;

EID: 84869016654     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.127     Document Type: Article

References (60)

1. Beckman, J.S., and Koppenol, W.H. (1996). Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am. J. Physiol. 271, C1424-C1437.
2. Beckman, J.S., Beckman, T.W., Chen, J., et al. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87, 1620-1624.
3. Channon, K.M., Qian, H., Neplioueva, V., et al. (1998a). In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation 98, 1905-1911.
4. Channon, K.M., Qian, H., Youngblood, S.A., et al. (1998b). Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. Circ. Res. 82, 1253-1262.
5. Chen, A.F.Y., O'Brien, T., Tsutsui, M., et al. (1997). Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery. Circ. Res. 80, 327-335.
6. Chen, L., Anton, M., and Graham, F.L. (1996). Production and characterization of human 293 cell lines expressing the sitespecific recombinase Cre. Somat. Cell Mol. Genet. 22, 477-488.
7. Chen, Y.H., Chang, M., and Davidson, B.L. (2009). Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy. Nat. Med. 15, 1215-1218.
8. Chia, S., Qadan, M., Newton, R., et al. (2003). Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler. Thromb. Vasc. Biol. 23, 695-701.
9. Conte, M.S. (2007). Molecular engineering of vein bypass grafts. J. Vasc. Surg. 45(Suppl A), A74-81.
10. Dronadula, N., Du, L., Flynn, R., et al. (2011). Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels. Gene Ther. 18, 501-508.
11. Du, L., Dronadula, N., Tanaka, S., and Dichek, D.A. (2011). Helper-dependent adenoviral vector achieves prolonged, stable expression of IL-10 in rabbit carotid arteries but does not limit early atherogenesis. Hum. Gene Ther. 22, 959-968.
12. Flugelman, M.Y., Jaklitsch, M.T., Newman, K.D., et al. (1992). Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation 85, 1110-1117.
13. Flynn, R., Buckler, J.M., Tang, C., et al. (2010). Helper-dependent adenoviral vectors are superior in vitro to first-generation vectors for endothelial cell-targeted gene therapy. Mol. Ther. 18, 2121-2129.
14. Flynn, R., Qian, K., Tang, C., et al. (2011). Expression of apolipoprotein A-I in rabbit carotid endothelium protects against atherosclerosis. Mol. Ther. 19, 1833-1841.
15. Furchgott, R.F. (1996). The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 276, 1186-1188.
16. Gaffney, M.M., Hynes, S.O., Barry, F., and O'Brien, T. (2007). Cardiovascular gene therapy: current status and therapeutic potential. Br. J. Pharmacol. 152, 175-188.
17. Gruchala, M., Bhardwaj, S., Pajusola, K., et al. (2004). Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. J. Gene Med. 6, 545-554.
18. Hayashi, T., Sumi, D., Juliet, P.A., et al. (2004). Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits. Cardiovasc. Res. 61, 339-351.
19. Horwitz, M.S. (1991). Adenoviridae and their replication. In Fundamental Virology. B.N. Fields and D.M. Knipe, eds. (Raven Press, New York) pp. 771-813.
20. Jiang, B., Qian, K., Du, L., et al. (2011). Helper-dependent adenovirus is superior to first-generation adenovirus for expressing transgenes in atherosclerosis-prone arteries. Arterioscler. Thromb. Vasc. Biol. 31, 1317-1325.
21. Kubes, P., Suzuki, M., and Granger, D.N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88, 4651-4655.
22. Kullo, I.J., Mozes, G., Schwartz, R.S., et al. (1997). Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. Hypertension 30, 314-320.
23. Lafont, A., Loirand, G., Pacaud, P., et al. (1997). Vasomotor dysfunction early after exposure of normal rabbit arteries to an adenoviral vector. Hum. Gene Ther. 8, 1033-1040.
24. Lemarchand, P., Jones, M., Yamada, I., and Crystal, R.G. (1993). In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ. Res. 72, 1132-1138.
25. Lindemann, D., and Schnittler, H. (2009). Genetic manipulation of endothelial cells by viral vectors. Thromb. Haemost. 102, 1135-1143.
26. Massey, P.G., Tanaka, S., Buckler, J., et al. (2009). Constriction of arteries by urokinase-type plasminogen activator requires catalytic activity and is independent of NH2-terminal domains. Thromb. Haemost. 102, 983-992.
27. McKay, R.G., Fram, D.B., Hirst, J.A., et al. (1994). Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: The Dispatch catheter. Cathet. Cardiovasc. Diagn. 33, 181-188.
28. Mozes, G., Kullo, I.J., Mohacsi, T.G., et al. (1998). Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine. Atherosclerosis 141, 265-271.
29. Mujynya-Ludunge, K., Viswambharan, H., Driscoll, R., et al. (2005). Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice. Basic Res. Cardiol. 100, 102-111.
30. Nabel, E.G., Plautz, G., Boyce, F.M., et al. (1989). Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 244, 1342-1344.
31. Newman, K.D., Dunn, P.F., Owens, J.W., et al. (1995). Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J. Clin. Invest. 96, 2955-2965.
32. O'Connor, D.M., and O'Brien, T. (2009). Nitric oxide synthase gene therapy: progress and prospects. Expert Opin. Biol. Ther. 9, 867-878.
33. Ohara, Y., Peterson, T.E., and Harrison, D.G. (1993). Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91, 2546-2551.
34. Ohashi, Y., Kawashima, S., Hirata, K., et al. (1998). Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J. Clin. Invest. 102, 2061-2071.
35. Onoue, H., Tsutsui, M., Smith, L., et al. (1998). Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29, 1959-1965; discussion 1965-1966.
36. Ooboshi, H., Toyoda, K., Faraci, F.M., et al. (1998). Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 18, 1752-1758.
37. Ozaki, M., Kawashima, S., Yamashita, T., et al. (2002). Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J. Clin. Invest. 110, 331-340.
38. Palmer, D.J., and Ng, P. (2005). Helper-dependent adenoviral vectors for gene therapy. Hum. Gene Ther. 16, 1-16.
39. Parks, R.J., Chen, L., Anton, M., et al. (1996). A helper-dependent adenovirus vector system: Removal of helper virus by Cremediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. U. S. A. 93, 13565-13570.
40. Qian, H., Neplioueva, V., Shetty, G.A., et al. (1999). Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 99, 2979-2982.
41. Qian, H.S., Channon, K., Neplioueva, V., et al. (2001). Improved adenoviral vector for vascular gene therapy: Beneficial effects on vascular function and inflammation. Circ. Res. 88, 911-917.
42. Radomski, M.W., Palmer, R.M., and Moncada, S. (1990). An Larginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. U. S. A. 87, 5193-5197.
43. Rome, J.J., Shayani, V., Flugelman, M.Y., et al. (1994). Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler. Thromb. 14, 148-161.
44. Sandig, V., Youil, R., Bett, A.J., et al. (2000). Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. U. S. A. 97, 1002-1007.
45. Schneider, D.B., Vassalli, G., Wen, S., et al. (2000). Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler. Thromb. Vasc. Biol. 20, 298-308.
46. Schulick, A.H., Dong, G., Newman, K.D., et al. (1995). Endothelium-specific in vivo gene transfer. Circ. Res. 77, 475-485.
47. Sharif, F., Hynes, S.O., McCullagh, K.J., et al. (2012). Geneeluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model. Gene Ther. 19, 321-328.
48. Takaya, T., Hirata, K., Yamashita, T., et al. (2007). A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. Arterioscler. Thromb. Vasc. Biol. 27, 1632-1637.
49. Terashima, T., Oka, K., Kritz, A.B., et al. (2009). DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice. J. Clin. Invest. 119, 2100-2112.
50. von der Leyen, H.E., Gibbons, G.H., Morishita, R., et al. (1995). Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. U. S. A. 92, 1137-1141.
51. von der Thu sen, J.H., Fekkes, M.L., Passier, R., et al. (2004). Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis. Arterioscler. Thromb. Vasc. Biol. 24, 357-362.
52. Wang, Q., and Finer, M.H. (1996). Second-generation adenovirus vectors. Nat. Med. 2, 714-716.
53. Wen, S., Schneider, D.B., Driscoll, R.M., et al. (2000). Secondgeneration adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall. Arterioscler. Thromb. Vasc. Biol. 20, 1452-1458.
54. Wen, S., Driscoll, R.M., Schneider, D.B., and Dichek, D. (2001). Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointimal formation after arterial gene transfer. Arterioscler. Thromb. Vasc. Biol. 21, 1777-1782.
55. Wen, S., Graf, S., Massey, P.G., and Dichek, D.A. (2004). Improved vascular gene transfer with a helper-dependent adenoviral vector. Circulation 110, 1484-1491.
56. Yamashita, T., Kawashima, S., Ohashi, Y., et al. (2000). Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36, 97-102.
57. Yla-Herttuala, S., and Martin, J.F. (2000). Cardiovascular gene therapy. Lancet 355, 213-222.
58. Zanetti, M., d'Uscio, L.V., Kovesdi, I., et al. (2003). In vivo gene transfer of inducible nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits. Stroke 34, 1293-1298.
59. Zeiher, A.M., Fisslthaler, B., Schray-Utz, B., and Busse, R. (1995). Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76, 980-986.
60. Zhang, C., Xu, X., Potter, B.J., et al. (2006). TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 26, 475-480.